These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 20531950

  • 1. Optimizing blood pressure control through the use of fixed combinations.
    Düsing R.
    Vasc Health Risk Manag; 2010 May 25; 6():321-5. PubMed ID: 20531950
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations.
    Bangalore S, Ley L.
    Expert Opin Pharmacother; 2012 Feb 25; 13(3):345-55. PubMed ID: 22220825
    [Abstract] [Full Text] [Related]

  • 5. Achieving Goal Blood Pressure.
    Laurent S.
    High Blood Press Cardiovasc Prev; 2015 Jul 25; 22 Suppl 1():S5-9. PubMed ID: 26002423
    [Abstract] [Full Text] [Related]

  • 6. Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
    Thomopoulos C, Katsimagklis G, Archontakis S, Skalis G, Makris T.
    Curr Vasc Pharmacol; 2017 Jul 25; 16(1):61-65. PubMed ID: 28413969
    [Abstract] [Full Text] [Related]

  • 7. Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.
    Volpe M, Tocci G, de la Sierra A, Kreutz R, Laurent S, Manolis AJ, Tsioufis K.
    High Blood Press Cardiovasc Prev; 2017 Dec 25; 24(4):463-472. PubMed ID: 29086364
    [Abstract] [Full Text] [Related]

  • 8. Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? A randomized controlled trial.
    Matsumura K, Arima H, Tominaga M, Ohtsubo T, Sasaguri T, Fujii K, Fukuhara M, Uezono K, Morinaga Y, Ohta Y, Otonari T, Kawasaki J, Kato I, Tsuchihashi T, COMFORT Investigators.
    Circ J; 2012 Dec 25; 76(6):1415-22. PubMed ID: 22447014
    [Abstract] [Full Text] [Related]

  • 9. Management of hypertension with fixed-dose triple-combination treatments.
    Epstein BJ, Shah NK, Borja-Hart NL.
    Ther Adv Cardiovasc Dis; 2013 Oct 25; 7(5):246-59. PubMed ID: 23945906
    [Abstract] [Full Text] [Related]

  • 10. Fixed-dose combination therapy in hypertension: cons.
    Angeli F, Reboldi G, Mazzotta G, Garofoli M, Ramundo E, Poltronieri C, Verdecchia P.
    High Blood Press Cardiovasc Prev; 2012 Jun 01; 19(2):51-4. PubMed ID: 22867089
    [Abstract] [Full Text] [Related]

  • 11. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM.
    Curr Med Res Opin; 2008 Aug 01; 24(8):2389-401. PubMed ID: 18616863
    [Abstract] [Full Text] [Related]

  • 12. Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?
    Riva N, Lip GY.
    Curr Pharm Des; 2013 Aug 01; 19(21):3753-65. PubMed ID: 23286431
    [Abstract] [Full Text] [Related]

  • 13. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.
    Gijón-Conde T, Sánchez-Martínez M, Graciani A, Cruz JJ, López-García E, Ortolá R, Rodríguez-Artalejo F, Banegas JR.
    J Hypertens; 2019 Jul 01; 37(7):1393-1400. PubMed ID: 31145710
    [Abstract] [Full Text] [Related]

  • 14. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME, Epstein BJ.
    J Cardiovasc Nurs; 2009 Jul 01; 24(5):380-9. PubMed ID: 19707098
    [Abstract] [Full Text] [Related]

  • 15. [Combination treatment of hypertension in 2015].
    Špinar J, Vítovec J, Špinarová L, Bendová M.
    Vnitr Lek; 2015 May 01; 61(5):458-65. PubMed ID: 26075856
    [Abstract] [Full Text] [Related]

  • 16. Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
    Chrysant SG.
    Postgrad Med; 2011 Nov 01; 123(6):21-31. PubMed ID: 22104451
    [Abstract] [Full Text] [Related]

  • 17. How do compliance, convenience, and tolerability affect blood pressure goal rates?
    Erdine S.
    Am J Cardiovasc Drugs; 2012 Oct 01; 12(5):295-302. PubMed ID: 22920049
    [Abstract] [Full Text] [Related]

  • 18. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL.
    J Am Pharm Assoc (2003); 2010 Oct 01; 50(5):e116-25. PubMed ID: 20833609
    [Abstract] [Full Text] [Related]

  • 19. Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan.
    Wang X, Chen H, Essien E, Wu J, Serna O, Paranjpe R, Abughosh S.
    J Manag Care Spec Pharm; 2019 Jun 01; 25(6):678-686. PubMed ID: 31134857
    [Abstract] [Full Text] [Related]

  • 20. A role for single-pill triple therapy in hypertension.
    Elijovich F, Laffer C.
    Ther Adv Cardiovasc Dis; 2009 Jun 01; 3(3):231-40. PubMed ID: 19443512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.